Immune checkpoint inhibition in malignant pleural mesothelioma and thymic epithelial tumors

被引：0
|
作者：
Park, Keunchil [1 ]
机构：
[1] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Hematol Oncol, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.424
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY4-2
引用
收藏
页码：S249 / S249
页数：1
相关论文
共 50 条
  • [21] Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: A Systematic Review and Meta-Analysis
    Gemelli, Maria
    Cortinovis, Diego Luigi
    Baggi, Alice
    di Mauro, Pierluigi
    Calza, Stefano
    Berruti, Alfredo
    Grisanti, Salvatore
    Rota, Matteo
    [J]. CANCERS, 2022, 14 (24)
  • [22] Combined Immune Checkpoint Blockade in Malignant Pleural Mesothelioma: In Vivo Validation of in Vitro Results
    Marcq, E.
    De Waele, J.
    Van Audenaerde, J.
    Jacobs, J.
    Van Loenhout, J.
    Pauwels, P.
    Smits, E.
    Van Meerbeeck, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S752 - S752
  • [23] Prominent Expression of the Negative Immune Checkpoint Regulator VISTA in Malignant Pleural Mesothelioma (MPM)
    Muller, Stephanie
    Zauderer, Marjorie
    Desmeules, Patrice
    Jungbluth, Achim
    Fayad, Miriam
    Frosina, Denise
    Ni, Ai
    Ladanyi, Marc
    Sauter, Jennifer L.
    [J]. LABORATORY INVESTIGATION, 2018, 98 : 743 - 743
  • [24] Where do immune checkpoint inhibitors stand in the management of thymic epithelial tumors?
    Saleh, Khalil
    Khalifeh-Saleh, Nadine
    Kourie, Hampig Raphael
    [J]. IMMUNOTHERAPY, 2018, 10 (10) : 823 - 826
  • [25] Immune checkpoint inhibition for the treatment of mesothelioma
    Nowak, Anna K.
    McDonnell, Alison
    Cook, Alistair
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (07) : 697 - 706
  • [26] Transcriptome sequencing of malignant pleural mesothelioma tumors
    Sugarbaker, David J.
    Richards, William G.
    Gordon, Gavin J.
    Dong, Lingsheng
    De Rienzo, Assunta
    Maulik, Gautam
    Glickman, Jonathan N.
    Chirieac, Lucian R.
    Hartman, Mor-Li
    Taillon, Bruce E.
    Du, Lei
    Bouffard, Pascal
    Kingsmore, Stephen F.
    Miller, Neil A.
    Farmer, Andrew D.
    Jensen, Roderick V.
    Gullans, Steven R.
    Bueno, Raphael
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (09) : 3521 - 3526
  • [27] Immunotherapy of Malignant Pleural Mesothelioma and Thymic Malignancies: The End of the Beginning?
    Van Meerbeeck, Jan
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S92 - S94
  • [28] Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesothelioma
    Hotta, Katsuyuki
    Fujimoto, Nobukazu
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [29] Immune Microenvironment and Genetics in Malignant Pleural Mesothelioma
    Wadowski, Benjamin
    Bueno, Raphael
    De Rienzo, Assunta
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [30] Malignant Pleural Mesothelioma: Staging and Radiological Response Criteria in Patients Treated with Immune Checkpoint Inhibitors
    Serafina Martella
    Marco Maria Aiello
    Valentina Bertaglia
    Riccardo Cau
    Nerina Denaro
    Andrea Cadoni
    Silvia Novello
    Mario Scartozzi
    Giuseppe Novello
    Hector Josè Soto Parra
    Luca Saba
    Cinzia Solinas
    Michele Porcu
    [J]. Targeted Oncology, 2024, 19 : 13 - 28
12345